Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to -$1.1 million.

  • Cytek Biosciences' Other Working Capital Changes fell 13079.34% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year decrease of 14055.57%. This contributed to the annual value of $3.7 million for FY2024, which is 6072.52% down from last year.
  • Latest data reveals that Cytek Biosciences reported Other Working Capital Changes of -$1.1 million as of Q3 2025, which was down 13079.34% from -$3.5 million recorded in Q2 2025.
  • Cytek Biosciences' Other Working Capital Changes' 5-year high stood at $6.4 million during Q2 2023, with a 5-year trough of -$4.1 million in Q2 2024.
  • Over the past 5 years, Cytek Biosciences' median Other Working Capital Changes value was $2.3 million (recorded in 2023), while the average stood at $2.1 million.
  • As far as peak fluctuations go, Cytek Biosciences' Other Working Capital Changes surged by 54175.39% in 2021, and later plummeted by 16356.0% in 2024.
  • Cytek Biosciences' Other Working Capital Changes (Quarter) stood at $3.4 million in 2021, then increased by 28.21% to $4.3 million in 2022, then crashed by 46.87% to $2.3 million in 2023, then tumbled by 39.41% to $1.4 million in 2024, then crashed by 177.46% to -$1.1 million in 2025.
  • Its Other Working Capital Changes was -$1.1 million in Q3 2025, compared to -$3.5 million in Q2 2025 and $1.3 million in Q1 2025.